Introduction
Cinacalcet Hydrochloride (HCl) is a calcimimetic agent used primarily to treat secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on dialysis and hypercalcemia in patients with parathyroid carcinoma. The growing prevalence of CKD and hyperparathyroidism globally has driven the demand for Cinacalcet HCl, making it a significant player in the...